Free Trial

XOMA (XOMAP) Competitors

XOMA logo
$25.62 -0.29 (-1.12%)
(As of 12/11/2024 ET)

XOMAP vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, and CEROW

Should you be buying XOMA stock or one of its competitors? The main competitors of XOMA include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and CERo Therapeutics (CEROW). These companies are all part of the "biotechnology" industry.

XOMA vs.

180 Life Sciences (NASDAQ:ATNFW) and XOMA (NASDAQ:XOMAP) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings, media sentiment, institutional ownership and community ranking.

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
XOMA N/A N/A N/A

180 Life Sciences and XOMA both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
XOMAN/AN/A

In the previous week, 180 Life Sciences and 180 Life Sciences both had 1 articles in the media. 180 Life Sciences' average media sentiment score of 1.87 beat XOMA's score of 0.93 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
180 Life Sciences Very Positive
XOMA Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
XOMA$9.71MN/AN/AN/AN/A

Summary

180 Life Sciences and XOMA tied by winning 1 of the 2 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

XOMAP vs. The Competition

MetricXOMABiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$166.88M$5.26B$9.28B
Dividend Yield9.29%3.50%5.12%3.95%
P/E RatioN/A326.32134.7817.62
Price / SalesN/A16,420.601,262.01141.14
Price / CashN/A11.6735.5735.65
Price / BookN/A7.344.824.95
Net IncomeN/A-$18.37M$119.04M$225.72M
7 Day Performance-1.14%0.49%1.50%1.70%
1 Month Performance-0.21%11.60%-0.56%5.09%
1 Year Performance13.74%35.96%33.02%29.01%

XOMA Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
XOMAP
XOMA
N/A$25.63
-1.1%
N/A+12.1%$0.00$9.71M0.0013
ATNFW
180 Life Sciences
N/A$0.01
-16.5%
N/A+21.3%$0.00N/A0.007Gap Down
SXTPW
60 Degrees Pharmaceuticals
N/A$0.02
+0.7%
N/A-22.6%$0.00$502,409.000.002Gap Up
DRTSW
Alpha Tau Medical
N/A$0.24
+4.1%
N/A+18.4%$0.00N/A0.0080Positive News
Gap Down
WENAW
Anew Medical
N/A$0.04
-0.3%
N/AN/A$0.00N/A0.00N/AGap Down
APLMW
Apollomics
N/A$0.01
-6.0%
N/A-76.2%$0.00N/A0.0059Short Interest ↑
BCTXW
BriaCell Therapeutics
N/A$0.50
+14.4%
N/A-68.8%$0.00N/A0.008Short Interest ↑
Positive News
Gap Down
High Trading Volume
CDIOW
Cardio Diagnostics
N/A$0.05
-6.2%
N/A+34.9%$0.00$35,688.000.007Short Interest ↓
High Trading Volume
CTCXW
Carmell
N/A$0.04
+4.9%
N/AN/A$0.00$32,839.000.009Gap Up
CELUW
Celularity
N/A$0.02
+31.2%
N/A+75.6%$0.00$42.69M0.00220Gap Up
CEROW
CERo Therapeutics
N/A$0.01
+30.6%
N/AN/A$0.00N/A0.008Short Interest ↑
Gap Up
High Trading Volume

Related Companies and Tools


This page (NASDAQ:XOMAP) was last updated on 12/12/2024 by MarketBeat.com Staff
From Our Partners